Search

John Kavouris Phones & Addresses

  • Woburn, MA
  • Watertown, CT
  • Folsom, CA
  • Cambridge, MA
  • Pittsburgh, PA
  • Merrionette Park, IL
  • Boston, MA
  • Calumet City, IL

Publications

Us Patents

Inhibitors Of Late Sv40 Factor (Lsf) As Cancer Chemotherapeutics

View page
US Patent:
20130324570, Dec 5, 2013
Filed:
Sep 30, 2011
Appl. No.:
13/879106
Inventors:
Ulla Hansen - Bedford MA, US
Scott Schaus - Boston MA, US
Trevor Grant - Allston MA, US
Joshua Bishop - Southborough MA, US
John Kavouris - Pittsburgh PA, US
Lisa M. Christadore - Pequannock NJ, US
Assignee:
TRUSTEES OF BOSTON UNIVERSITY - Boston MA
International Classification:
A61K 31/4741
A61K 31/4704
US Classification:
514291, 546 90, 514312, 546158
Abstract:
The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present invention discloses the use of a small-molecule compound of formulas (I)-(XXVI) as disclosed herein to inhibit transcription factor Late SV40 Factor (LSF) for treatment of cancer, e.g., HCC.

Inhibitors Of Late Sv40 Factor (Lsf) As Cancer Chemotherapeutics

View page
US Patent:
20180051033, Feb 22, 2018
Filed:
Sep 25, 2017
Appl. No.:
15/713956
Inventors:
- Boston MA, US
Scott Schaus - Boston MA, US
Trevor Grant - Vernon CT, US
Joshua Bishop - Belmont MA, US
John Kavouris - Pittsburgh PA, US
Lisa M. Christadore - Brighton MA, US
Assignee:
TRUSTEES OF BOSTON UNIVERSITY - Boston MA
International Classification:
C07D 491/056
C07D 215/227
Abstract:
The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present invention discloses the use of a small-molecule compound of formula (I)-(XXVI) and (III′) as disclosed herein to inhibit transcription factor Late SV40 Factor (LSF) for treatment of cancer, e.g., HCC.

Inhibitors Of Late Sv40 Factor (Lsf) As Cancer Chemotherapeutics

View page
US Patent:
20170107227, Apr 20, 2017
Filed:
Dec 23, 2016
Appl. No.:
15/389564
Inventors:
- Boston MA, US
Scott Schaus - Boston MA, US
Trevor Grant - Vernon CT, US
Joshua Bishop - Belmont MA, US
John Kavouris - Pittsburgh PA, US
Lisa M. Christadore - Brighton MA, US
Assignee:
TRUSTEES OF BOSTON UNIVERSITY - Boston MA
International Classification:
C07D 491/056
Abstract:
The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present invention discloses the use of a small-molecule compound of formula (I)-(XXVI) and (III′) as disclosed herein to inhibit transcription factor Late SV40 Factor (LSF) for treatment of cancer, e.g., HCC.

Inhibitors Of Late Sv40 Factor (Lsf) As Cancer Chemotherapeutics

View page
US Patent:
20170044175, Feb 16, 2017
Filed:
Oct 28, 2016
Appl. No.:
15/337584
Inventors:
- Boston MA, US
Scott Schaus - Boston MA, US
Trevor Grant - Vernon CT, US
Joshua Bishop - Belmont MA, US
John Kavouris - Pittsburgh PA, US
Lisa M. Christadore - Brighton MA, US
Assignee:
TRUSTEES OF BOSTON UNIVERSITY - Boston MA
International Classification:
C07D 491/056
C07D 215/227
Abstract:
The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present invention discloses the use of a small-molecule compound of formula (I)-(XXVI) and (III′) as disclosed herein to inhibit transcription factor Late SV40 Factor (LSF) for treatment of cancer, e.g., HCC.
John A Kavouris from Woburn, MA, age ~35 Get Report